Sun Pharmaceuticals reported INR226.22B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Aspen Pharmacare ZAR 15.77B 1.73B Dec/2025
Bharat Petroleum INR 884.32B 22.4B Sep/2025
Cipla INR 70.14B 7.16B Mar/2026
Dr.Reddys Laboratories INR 167.47B 9.16B Mar/2026
Jiangsu Hengrui CNY 5.64B 732.51M Mar/2026
Sh Fosun Pharma CNY 36.58B 156.4M Mar/2026
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
UPL INR 347.48B 16.58B Mar/2026